Seegene Inc
PO BOX 505208
Building 49 Level 5
Seegene Middle East Seegene's goal is contributing to improve public heath by developing cutting edge technologies and MDX products that can diagnose diseases at the genetic level. Seegene has devoted to all its effort to the acquirements of core technologies and valuable products in Multiplex MDx since established in 2000, has brought a paradigm shift in the molecular diagnosis market that was previously dominated by a few major companies. Seegene has developed various Multiplex MDX products for the simultaneous detection and quantification of multiple pathogens in infectious diseases.
